| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 39.9004 | 6 |
| GSM780708 | Untreated after 4 days (C2_1) | 43.0842 | 18 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.8282 | 26 |
| GSM780719 | Untreated after 4 days (C1_2) | 42.7826 | 16 |
| GSM780720 | Untreated after 4 days (C2_2) | 40.0344 | 7 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.0271 | 18 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.2727 | 33 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.3238 | 19 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 41.9459 | 13 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 42.3814 | 15 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 39.5239 | 5 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.1924 | 18 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.0189 | 41 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.5805 | 20 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 50.0394 | 49 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 54.899 | 59 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 43.8126 | 21 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.5081 | 47 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.3566 | 29 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.9569 | 22 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 41.7935 | 12 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 40.1844 | 7 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.8591 | 31 |